Skip to main content
SpringerLink
Log in

Pravastatin, a 3-hydroxy-3-methyl-glutharyl coenzyme A inhibitor does not show pleiotropic effects in patients with systemic lupus erythematosus

  • Letter to the Editor
  • Published:
Rheumatology International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Costenbader KH, Liang MH, Chibnik LB et al (2007) A pravastatin dose-escalation study in systemic lupus erythematosus. Rheumatol Int 27:1071–1077

    Article  PubMed  CAS  Google Scholar 

  2. Wajed J, Ahmad P, Durrington N, Bruce IN (2004) Prevention of cardiovascular disease in systemic lupus erythematosus—proposed guidelines for risk factor management. Rheumatology 43:7–12

    Article  PubMed  CAS  Google Scholar 

  3. Kotyla P, Sliwinska-Kotyla B (2008) Therapeutic potential of HMG-CoA reductase inhibitors (statins) in systemic lupus erythematosus. In: Stevard TI (ed) Progress in systemic lupus erythematosus research. Nova Science Publishers, New York, pp 227–243

    Google Scholar 

  4. Kotyla PJ, Sliwinska-Kotyla B, Kucharz EJ (2006) TNF alpha as a potential target in the treatment of SLE: a role for the HMG-CoA reductase inhibitor simvastatin. J Rheumatol 33:2361

    PubMed  Google Scholar 

  5. Ferreira GA, Navarro TP, Telles RW, Andrade LEC, Sat I (2007) Atorvastatin therapy improves endothelial-dependent vasodilatation in patients with systemic lupus erythematosus: an 8 weeks controlled trial. Rheumatology 46:1560–1565

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine and Rheumatology, Medical University of Silesia, Ul Ziolowa 45/47, 40-635, Katowice, Poland

    Przemyslaw J. Kotyla

Authors
  1. Przemyslaw J. Kotyla
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Przemyslaw J. Kotyla.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kotyla, P.J. Pravastatin, a 3-hydroxy-3-methyl-glutharyl coenzyme A inhibitor does not show pleiotropic effects in patients with systemic lupus erythematosus. Rheumatol Int 29, 353–354 (2009). https://doi.org/10.1007/s00296-008-0683-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-008-0683-8

Keywords

Search

Navigation